CORRECTION article

Front. Immunol., 02 July 2019

Sec. Cancer Immunity and Immunotherapy

Volume 10 - 2019 | https://doi.org/10.3389/fimmu.2019.01523

Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades

  • 1. Clinical Epidemiology Unit, Qilu Hospital of Shandong University, Jinan, China

  • 2. Key Laboratory of Cancer Prevention and Therapy of Tianjin, Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

  • 3. Key Laboratory of Cancer Prevention and Therapy, Department of Breast Cancer Pathology and Research Laboratory, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

  • 4. Department of Respiratory Medicine, Central Hospital of Zibo, Zibo, China

  • 5. Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China

  • 6. Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China

  • 7. Department of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, Chongqing, China

In the published article, there was an error in affiliation “1.” Instead of “Shandong Academy of Clinical Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China,” it should be “Clinical Epidemiology Unit, Qilu Hospital of Shandong University, Jinan, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

LRP1B, melanoma, NSCLC, tumor mutation burden, immunotherapy, mutation signatures

Citation

Chen H, Chong W, Wu Q, Yao Y, Mao M and Wang X (2019) Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades. Front. Immunol. 10:1523. doi: 10.3389/fimmu.2019.01523

Received

17 June 2019

Accepted

18 June 2019

Published

02 July 2019

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2019

Updates

Copyright

*Correspondence: Min Mao Xin Wang

This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics